Last Updated: June 29, 2026

List of Excipients in API nitrofurantoin monohydrate


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing nitrofurantoin monohydrate

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
PharmPak Inc NITROFURANTOIN MONO nitrofurantoin monohydrate 54348-849 CARBOMER HOMOPOLYMER TYPE B
PharmPak Inc NITROFURANTOIN MONO nitrofurantoin monohydrate 54348-849 D&C YELLOW NO. 10
PharmPak Inc NITROFURANTOIN MONO nitrofurantoin monohydrate 54348-849 FD&C BLUE NO. 1
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Start Trial

Excipients in ANDA-approved (generic) drugs containing nitrofurantoin monohydrate

Company Ingredient NDC Excipient
Mylan Pharmaceuticals Inc nitrofurantoin monohydrate and nitrofurantoin, macrocrystalline 0378-3422 ALGINIC ACID
Mylan Pharmaceuticals Inc nitrofurantoin monohydrate and nitrofurantoin, macrocrystalline 0378-3422 ANHYDROUS DIBASIC CALCIUM PHOSPHATE
Mylan Pharmaceuticals Inc nitrofurantoin monohydrate and nitrofurantoin, macrocrystalline 0378-3422 CELLULOSE, MICROCRYSTALLINE
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Start Trial

Detailed excipient profiles for nitrofurantoin monohydrate

Excipient focus: ALCOHOL

Excipient focus: ALGINIC ACID

Excipient focus: AMMONIA

Excipient focus: ANHYDROUS DIBASIC CALCIUM PHOSPHATE

Excipient focus: BUTYL ALCOHOL

Excipient focus: CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS

Excipient focus: CARBOMER 934

Excipient focus: CARBOMER HOMOPOLYMER TYPE B

nitrofurantoin monohydrate drug variants not containing CARBOMER HOMOPOLYMER TYPE B

Company Ingredient NDC
Mylan Pharmaceuticals Inc nitrofurantoin monohydrate and nitrofurantoin, macrocrystalline 0378-3422
Physicians Total Care Inc nitrofurantoin monohydrate and nitrofurantoin, macrocrystalline 54868-6203
Central Texas Community Health Centers nitrofurantoin monohydrate and nitrofurantoin, macrocrystalline 76413-115
>Company >Ingredient >NDC

Subscribe to access the full database, or Start Trial

Excipient focus: CARBOXYMETHYLCELLULOSE

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: CROSPOVIDONE

Excipient focus: D&C YELLOW NO. 10

Excipient focus: FD&C BLUE NO. 1

Excipient focus: FD&C BLUE NO. 2

Excipient focus: FD&C RED NO. 40

Excipient focus: FD&C YELLOW NO. 6

Excipient focus: FERRIC OXIDE RED

Excipient focus: FERRIC OXIDE YELLOW

Excipient focus: FERROSOFERRIC OXIDE

Excipient focus: GELATIN

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSES

Excipient focus: ISOPROPYL ALCOHOL

Excipient focus: LACTOSE

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: MAGNESIUM STEARATE

Excipient focus: MALTODEXTRIN

Excipient focus: POTASSIUM HYDROXIDE

Excipient focus: POVIDONE

Excipient focus: POVIDONES

Excipient focus: PROPYLENE GLYCOL

Excipient focus: SHELLAC

Excipient focus: SODIUM ALGINATE

Excipient focus: SODIUM HYDROXIDE

Excipient focus: SODIUM LAURYL SULFATE

Excipient focus: STARCH, CORN

Excipient focus: SUCROSE

Excipient focus: TALC

Excipient focus: TITANIUM DIOXIDE

Excipient focus: WATER

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2026 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2026 - 2027
 NCE-1 Patent Challenge Dates 2026 - 2027
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links